STK26 and hepatocellular carcinoma: In hepatocellular carcinoma (HCC), the high expression of STK26 was associated with large tumor size, microvascular invasion, intrahepatic metastasis, and TNM grading of patients with advanced HCC, which was independent prognostic factor of the overall survival rate (P = 0.004) and time to recurrence (P = 0.001) of patients after hepatectomy [30].